A prospective and observational study to evaluate short-term adverse event following immunization of COVID-19 vaccination

Simple item page
dc.contributor.authorWaraich, HSen_US
dc.contributor.authorVardhan, Gen_US
dc.contributor.authorKumar, Ven_US
dc.contributor.authorBhardwaj, H.en_US
dc.date.accessioned2023-06-27T06:37:59Z
dc.date.available2023-06-27T06:37:59Z
dc.date.issued2022-07
dc.description.abstractBackground: COVID-19 severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) was declared Pandemic by the World Health Organization on January 30, 2020. Vaccination represents the best possibility to resolve this pandemic. The current global challenge is the immunization against the SARS-CoV-2. However, the adverse events following immunization (AEFI) of the corona vaccine remains unclear. Aim and Objectives: This observational study aims to represent an accountable data of the AEFI between Covaxin and Covishield in North Indian population. Materials and Methods: The hospital-based prospective and observational study was employed from January 2021 to December 2021 for detecting and monitoring of AEFI in adults. All population vaccinated either covishield or covaxin with both doses were enrolled in the study as targeted population. Post-vaccination vaccinated population were telephonic follow-up with prior consent. Results: A total of 1015 vaccinated individuals were included in this study for assessment of AEFI. After statistical analysis of AEFI between both vaccination at 24 h P = 0.13, 3–7 days 0.4 and complete AEFI P = 0.06 observed. There is no association that was found significant P < 0.05 with the incidence of AEFI. Conclusion: The short-term outcome has not attribute any serious AEFI. This study demonstrated that both vaccines were well-tolerated and safe in generalized population.en_US
dc.identifier.affiliationsDepartment of Pharmacology, Government Medical College, Amritsar, Punjab, Indiaen_US
dc.identifier.affiliationsDepartment of Pharmacology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, Indiaen_US
dc.identifier.affiliationsDepartment of Neurology, Akash Health Care, New Delhi, Indiaen_US
dc.identifier.citationWaraich HS, Vardhan G, Kumar V, Bhardwaj H.. A prospective and observational study to evaluate short-term adverse event following immunization of COVID-19 vaccination. National Journal of Physiology, Pharmacy and Pharmacology. 2022 Jul; 12(7): 1033-1037en_US
dc.identifier.issn2231-3206
dc.identifier.issn2320-4672
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/217628
dc.languageenen_US
dc.publisherMrs Dipika Charan of MedScience (India) Publicationsen_US
dc.relation.issuenumber7en_US
dc.relation.volume12en_US
dc.source.urihttps://dx.doi.org/10.5455/njppp.2022.12.04168202223052022en_US
dc.subjectCOVID-19en_US
dc.subjectCovishielden_US
dc.subjectCovaxinen_US
dc.subjectImmunizationen_US
dc.subjectAdverse Events Following Immunizationen_US
dc.titleA prospective and observational study to evaluate short-term adverse event following immunization of COVID-19 vaccinationen_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
NJPPP2022v12n7p1033.pdf
Size:
306.6 KB
Format:
Adobe Portable Document Format
Download
Collections
National Journal of Physiology, Pharmacy and Pharmacology